Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$IVDN: Agreement Signed for Energy Saving Insulation with a Minimum $2 Million Yearly Contract: Innovative Designs
Click here:
https://www.einpresswire.com/article/605952244/agreement-signed-for-energy-saving-insulation-with-a-minimum-2-million-yearly-contract-innovative-designs-otcqb-ivdn
$MLRT - MetAlert, Inc. has selected Pod Group’s ENO ONE IoT SIM cards and advanced connectivity solutions for enterprise IoT applications for its award-winning 2-way GPS SmartSole, a wearable medical monitoring device that is integrated into an orthotic insole allowing discreet and unobtrusive tracking and remote monitoring of Alzheimer’s, Dementia, and Autism sufferers.
This week, the GPS SmartSoles was also featured on the Gadget Guys shares the latest tech perfect for the holiday season which aired on the CW syndicate across the U.S. and reaches approximately 3.2 million households.
https://www.globenewswire.com/news-release/2022/11/02/2546844/0/en/MetAlert-Partners-with-POD-Group-and-Selects-ENO-ONE-eSIM-IoT-Connectivity-for-SmartSole-Platform.html
$GMPR News: Gourmet Provisions International Corp. (GMPR) Announces Maryland Save a Lot Grocery Stores Locations
https://www.globenewswire.com/news-release/2022/09/30/2525998/0/en/Gourmet-Provisions-International-Corp-GMPR-Announces-Maryland-Save-a-Lot-Grocery-Stores-Locations.html
$NGTF Feature Article: New Chocolate Chip Cookie Launch to go with Multiple Ice Creams as Hotels Wake up to Sleep-Friendly Nighttime Snacks
Click here:
https://markets.financialcontent.com/bostonherald/article/getnews-2022-8-30-new-chocolate-chip-cookie-launch-to-go-with-multiple-ice-creams-as-hotels-wake-up-to-sleep-friendly-nighttime-snacks/
$CURR: CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children’s Hospital Medical Center (CCHMC) Using CURE’s Proprietary, Oral Thin Film (OTF) High, Single Dose Vitamin D in Pediatric Patients Pre- and Post-Hematopoietic St
CURE’s Patented and Proprietary OTF Vitamin D Found to be More Effective than Standard Supplementation in Achieving pre- and post-Surgery Vitamin D Sufficiency Necessary to Reduce Immune-Mediated Damage such as Graft Versus Host Disease (GVHD)
CCHMC to Seek Formulary approval for CURE’s OTF Vitamin D Supplement in its Hospital Formulary
OXNARD, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holdings (OTC: CURR), a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, today announced positive finding from a study conducted at Cincinnati Children’s Hospital Medical Center (CCHMC) using CURE’s proprietary, single dose, oral, 40,000 IU vitamin D (branded ImmunD3™ Nutri-Strips™ in the retail wellness market) in pediatric patients before stem cell therapy. CURE’s oral Vitamin D supplement was found to be more effective than standard supplementation in achieving pre- and post-surgery vitamin D sufficiency, which is critical for reducing immune-mediated organ damage in the children receiving HSCT.
To view the details of this study, visit the poster presentation on CURE’s website at https://curepharmaceutical.com/white-papers/
“The findings for our proprietary, oral thin film Vitamin D, which we brand as ImmunD3 NutriStrips, is quite remarkable for its ability to improve bone health and reduce complications in pediatric patients and brings additional hope to the parents and their children who undergo HSCT stem cell therapy, for life-threatening diseases,” said CURE Pharmaceutical CEO Rob Davidson. “If we can reduce the risks of complications by bringing these children up to optimal Vitamin D levels before surgery, and in the acute post-transplantation period, we’ve helped to reduce pain and suffering and potentially saved lives.”
Next Steps: Adding CURE’s oral Vitamin D to Formularies Nationwide
Since previous attempts to improve vitamin D deficiency in these young patients using additional doses and/or higher dosing of enteral vitamin D are often not successful, CCHMC is working with its Formulary to add CURE’s NutriStrip Vitamin D formulation to its list of approved treatments.
Davidson added: “We are also pleased that the CCHMC team found these results to be so compelling as to commence the process to include what we call “ImmunD3 Nutri-Strips™” in their hospital’s Formulary. In light of this advancement, we plan to reach out to other children’s hospitals around the U.S. in order to share these compelling findings and seek the addition of our proprietary Vitamin D into their Formularies.”
Using CURE’s proprietary delivery technology is important because it overcomes the numerous barriers that impede adequate replacement with conventional vitamin D therapy. Some of these obstacles include:
malabsorption secondary to gut GVHD
the inability to take capsules
Mucositis
Kidney disease
Liver disease
Infection
More About the Study
The CCHMC study found that compliance and tolerance likewise improved, with patients and parents expressing a preference for the strips. The median age of the study cohort was 8 years, with a range of 1-28 years old, dosing varied significantly, from 1 strip monthly to 4 strips weekly and all patients showed improvement in serum vitamin D levels by week 4 on study. The median vitamin D level at baseline was 29.4 ng/mL, significantly improved (p Median vitamin D level at baseline was 29.4 ng/mL, significantly improved (p 0.0001) to 5.5ng/mL at the end of the study).
About Vitamin D and Pediatric Hematopoietic Stem Cell Transplantation Patients
Vitamin D is essential for bone health and has immunomodulatory properties. Most pediatric patients are vitamin D insufficient (<30 ng/mL) before HSCT. Standard supplementation strategies fail to achieve vitamin D sufficiency in the acute post-transplantation period, and there are scarce data to support optimal vitamin D supplementation in this patient population. This study, the poster of which can be found here: https://curepharmaceutical.com/white-papers/ sought to evaluate whether a single, oral, weight-based ultra-high dose of vitamin D was more effective than standard supplementation in achieving pre-HSCT vitamin D sufficiency and reducing the incidence of HSCT-related complications (acute graft-versus-host disease, veno-occlusive disease, and/or transplant-associated thrombotic microangiopathy) that are associated with immune-mediated endothelial damage. Secondary endpoints examined the immunomodulatory properties of vitamin D.
About CURE Pharmaceutical
CURE Pharmaceutical® is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. Among CURE’s key products is its oral thin film, 40,000 IU dose Vitamin D, (Branded Nutri-Strips™ in the Retail Market). Each strip is hermetically sealed in airtight, grab-and-go packaging to eliminate chemical and structural breakdown and provide superior potency. Nutri-Strips™ are available online at https://www.nutristripnow.com/immund3
As a vertically integrated company, CURE’s 25,000 square foot, FDA-registered, NSF® and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
Forward Looking Statements
Statements CURE makes in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”), which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. CURE intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act and is making this statement for purposes of complying with those safe harbor provisions. The forward-looking statements in this press release reflect CURE’s judgment as of the date of this press release. CURE disclaims any intent or obligation to update these forward-looking statements.
Contacts:
Investor Relations
investor@curepharma.com
(805) 410-9962 ext. 4
CLNV will work on numerous projects in Sri Lanka, India, and Somaliland!!
As part of Clean Vision's plan in India, it would deploy fuel cells at standalone locations mandated by the government in order to minimize their pull from the grid by more than 30%. As a consequence, it expects to have fuel cells in the Indian market by the third quarter of 2022. CLNV is transforming the green energy sector.
https://www.influencive.com/clean-vision-addresses-the-issue-of-plastic-waste-in-the-oceans/
$QUAN Nice updated trend https://www.marketwatch.com/investing/stock/quan/charts?mod=mw_quote_tab
$HECOF HECO The Global Helium team brings over two decades of helium-specific experience.
https://www.l3opptrk.com/3J67C1/3KNS3X3/
$GTCH "Upon robust code modifications completion, we are concluding our qTerm human vitals device. qTerm GEN III went through enclosure structure, electronics and software changes and we believe it is now ready for commercialization. The most recent code enhancements were aimed to further improve human/device temperature reporting and measurements interactions. Due to the temperature sensitivity of human’s extremities it's a challenging task to measure body temperature taking into effect the ambient and external conditions. For example, if a user measures his/her body temperature immediately after being in a cold or hot environment, it may lead to an inaccurate result due to the affected finger’s extremity temperature. In such case the device will warn to wait in a normal room temperature for temperature stabilization before re-measuring vitals. The device will be accompanied by a mobile application for iOS and Android platforms, connected via Bluetooth. A synchronized web-based widget will be available on qTerm’s web site to enabling viewing user’s anywhere around the world. The widget also provides historical information, analytics and health related charts, making qTerm an efficient technology for worldwide telemedicine. Our Artificial Intelligence technology is the system’s brains and will be trained with the user’s vitals data. It will process the data, keep history, perform analytics, and provide an ongoing, personal health monitoring. The system will have API capabilities to easily connect to hospitals and clinics computerized health systems. We are now looking into qTerm’s commercialization and evaluating production possibilities. The fact that qTerm’s readings can be viewed worldwide, we believe this makes it a robust telemedicine technology to keep our lives safer and healthier,” said Danny Rittman, the Company’s CTO.
https://www.marketwatch.com/press-release/gbt-is-concluding-its-qterm-vitals-device-with-temperature-measurement-algorithms-enhancements-2022-03-22?mod=mw_quote_news_seemore
$QUAN Some DD here https://www.marketwatch.com/investing/stock/quan/charts?mod=mw_quote_tab
BBBT - Black Bird Biotech's Partnership with Spire + Will Expand Current Markets
Black Bird Biotech (OTC:BBBT) provides insight into plant-based biopesticides made entirely of food-grade chemicals, which help to protect both our food supplies and the environment. They've partnered with Spire+ to brand and advertise the MiteXtream biopesticide. A new product from Black Bird Biotech is gaining traction - they're on the rise in terms of revenue and share price! Add BBBT to your Watchlist to keep an eye on them...
https://www.accesswire.com/692885/Black-Bird-Biotech-Enters-Agreement-with-Sales-and-Marketing-Consulting-Firm-Spire-to-Expedite-Brand-Growth
$QUAN Interesting article here: https://walletinvestor.com/stock-forecast/quan-stock-prediction
$IVDN: Far Surpassing All Competition in Performance with Patented Technology for the Multi-Billion Dollar Insulation Products Markets: Innovative Designs, Inc. (OTCQB: IVDN)
Feature Article here:
https://markets.financialcontent.com/startribune/news/read/42235626/
CEO Interview here:
$BIEL The Exciting Story of BioElectronics Corp.
https://microcapdaily.com/the-exciting-story-of-bioelectronics-corp-otcpink-biel/
https://microcapdaily.com/bioelectronics-corp-otcpink-biel-getting-noticed-fast-as-biotech-inks-new-orders-initiates-new-studies-and-its-recoveryrx-actipatch-gain-traction/
https://microcapdaily.com/bioelectronics-corp-otcpink-biel-major-reversal-as-pain-management-pioneer-reports-record-revenues-readies-launch-of-its-kt-recovery-wavetm-in-the-uk/
https://www.otcdynamics.com/biel-bioelectronics-recoveryrx-pain-relief-device-receives-clearance-from-cofepris-launching-distribution-in-mexico/
Best Penny Stock To Own in 2022 (5 Major Catalysts Incoming)
$NECA -- News on high potential move to surge revenue growth in 2022:
LOI Submitted for Leading Cabinetry Manufacturer Adding Top and Bottom-Line Numbers
NEW YORK, NY / ACCESSWIRE/ March 15, 2022 / New America Energy Corp. (OTC PINK:NECA), is pleased to announce that the Company, through its subsidiary Third Bench Holdings, LLC ("Third Bench"), has submitted a Letter of Intention to acquire a leading cabinetry manufacturer in Phoenix.
The target is a leader in the cabinetry manufacturing for the multi-family residential market in the Phoenix metro area. The Target generated about $7.7M of annual revenue in 2021 with approximately $1.5M of Net Income and we expect the Target to generate at least $10M in revenue in 2022. The Target would also provide Third Bench with the ability to cross-sell proprietary multifamily products throughout the rest of the established Third Bench markets.
Third Bench CEO David Fair states, "We are thrilled to add a line of residential cabinets to Third Bench and to add an operation in Phoenix, which is one of the highest growth markets in the country! This target would put Third Bench well over $30 Million in revenue and add to our already positive cashflow. Acquiring this Target will provide Third Bench with the ability to supply a proprietary line cabinet to our multi-family customers and will make us one of the largest suppliers of residential cabinetry in the Southwestern United States. We are hopeful that we can complete the execution of the LOI within the next couple of weeks."
Mr. Fair goes on to say "Today, almost 15% of the residential cabinetry sold by Third Bench is supplied to multi-family developments. Manufacturing our own line will allow us to be very price competitive and capture a larger margin when selling into the multi-family sector. In addition, we regularly pass on multi-family opportunities because we are unable to meet the supply and be price competitive. There are an extensive number of opportunities with this target!"
About Third Bench Holdings, LLC
THIRD BENCH Holdings is a holding company for three subsidiary companies operating as an architectural millwork and dealers in the cabinetry, kitchen and bath areas. THIRD BENCH, through its subsidiary companies, offers products in categories: Residential Cabinets and countertops and commercial millwork throughout the Western U.S. for customers from California to Texas. THIRD BENCH also provides installation services as a part of its vertical offering. Third Bench employs over 150 people and had revenue of about $24 million in 2021. Third Bench is on a run rate of $30.0 million for 2022 and is cashflow positive. These projections have been provided by management and do not include the additional acquisitions that are currently under review.
Third Bench Holdings
175 S. Main Street #1410
Salt Lake City, UT 84111
https://thirdbench.com/
NECA Contact:
Investor Relations
info@thirdbench.com
https://twitter.com/necaholdings
NOTICE REGARDING FORWARD-LOOKING STATEMENT
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance, or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
SOURCE: New America Energy Corp.
View source version on accesswire.com:
https://www.accesswire.com/692999/LOI-Submitted-for-Leading-Cabinetry-Manufacturer-Adding-Top-and-Bottom-Line-Numbers
IDEX Powering the Largest Wireless Fleet in the U.S.
WAVE’s high power wireless charging systems offer a modular solution (125kW to 500kW) across a broad range of commercial applications, including mass transit, ports, warehouse and distribution centers. The largest electric mass transit bus fleet in the US is powered by WAVE.
https://ideanomics.com/
Gold and Silver Prices Explode and THEN DO WHAT?!?
$RBNW News: Lust for Life Footwear Meeting Strong Consumer Demand for Early Fall Boots Currently Receiving New Orders for Spring/Summer Season
Click here:
https://finance.yahoo.com/news/lust-life-footwear-meeting-strong-133000147.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
About Renewable Energy & Power, Inc.:
Renewable Energy & Power, Inc. (OTC PINK:RBNW) is the parent company to Lust for Life Group. RBNW is a holding company for apparel lines with both direct to consumer and wholesale sales to national retail chains. Previously, RBNW was focused on renewable energy projects, however in August 2019, with the acquisition of Blind Faith Concepts, Inc., which holds 100% of Lust for Life, LLC, RBNW's management determined to shift operations to focus on apparel. For more information on RBNW, visit http://www.lustforlifeshoes.com.
$SNPW: Sun Pacific Holding Corp. Launches new website link to offer FoxESS Inverter and Energy Storage Solution Products for North America, South America and Australia
Click here:
https://www.globenewswire.com/news-release/2022/01/25/2372699/0/en/Sun-Pacific-Holding-Corp-Launches-new-website-link-to-offer-FoxESS-Inverter-and-Energy-Storage-Solution-Products-for-North-America-South-America-and-Australia.html
This Is Dire For Silver Supply!! - Andy Schectman | Silver Shortage
Investing In Gold Will Lose Your Money | Gary Wagner Gold Price Prediction
$BANT: Bantec, through Bantec Sanitizing, Sold Training, Equipment and Covid Sterilizing Products to an Ivy League University
LITTLE FALLS, N.J., Dec. 7, 2021 /PRNewswire/ -- Bantec, Inc. (OTCPINK: BANT) ("Bantec" or the "Company"), Bantec, Inc., through its subsidiary Bantec Sanitizing, sold Training and Covid Sterilizing Products to an Ivy League University.
Michael Bannon, Bantec's Chairman and CEO, stated: "The University made the decision to coat exterior windows with Pureti in order to efficiently clean and sanitize the glass surfaces. Pureti improves human health by reversing pollution inside and out. In addition, it conserves resources by reducing water and chemical use, improving appearance and customer experience, and reducing maintenance costs. We provided the University the equipment, products and the training needed to apply Pureti and EnviroPro. EnviroPro, a LEED product, hydrogen peroxide based, multipurpose germicidal, fungicidal and virucidal disinfectant, sanitizes hard, non-porous, inanimate surfaces. We intend to generate 2022 revenue by offering this suite of services to other colleges and universities."
About Bantec Sanitizing
Bantec Sanitizing, a division of Bantec, provides a variety of products and services to help facility managers, safety professionals, and maintenance personnel combat a multitude of airborne and surface hazards. On February 3rd, 2021, Bantec announced that it will offer Bantec Sanitizing (Exposure Response Mobile Service) as a Franchise. Future Bantec Sanitizing franchisees will offer Bantec Sanitizing supplies, robots, UV lights and deep cleaning services. If you have interest in becoming a Bantec Sanitizing Franchisee, please go to the Bantec Sanitizing Facebook page: https://www.facebook.com/bantecsanitizing/
About Bantec
Bantec, Inc, a product and services company, through its subsidiaries and divisions sells to facility managers, engineers, maintenance managers, purchasing managers and contract officers who work for hospitals, universities, manufacturers, commercial businesses, local and state governments, and the US government. We intend to grow different businesses line of businesses, possibly using the franchise model, which support the customers described above.
Forward-Looking Statements
Certain statements in this press release may be considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include projections of matters that affect revenue, operating expenses, or net earnings; projections of growth; and assumptions relating to the foregoing. Such forward-looking statements are generally qualified by terms such as: "plans, "anticipates," "expects," "believes" or similar words. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or qualified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking information. These factors are discussed in greater detail in our Form 10 filed with the U.S. Securities and Exchange Commission.
Contacts:
Michael Bannon
Chairman & CEO
mike@bantecinc.com
https://c212.net/c/img/favicon.png?sn=IO98949&sd=2021-12-07 View original content:https://www.prnewswire.com/news-releases/bantec-through-bantec-sanitizing-sold-training-equipment-and-covid-sterilizing-products-to-an-ivy-league-university-301439037.html
SOURCE Bantek Inc.
$KXIN Shencheng will purchase 10,000 customized new energy trucks from Kaixin over the next 5 years.
$SPZI This Interview was conducted on Sunday12-26-21at approximately 10:30 AM EST with Tony Sylvester, Errol Stone and Paul Strickland.
$NGTF: New Letter to Shareholders is very comprehensive and informative on the company's expanding success in marketing its highly popular Nightfood ice cream line.
Nightfood Letter to Shareholders - December 16, 2021
Link: https://www.sec.gov/Archives/edgar/data/1593001/000121390021065710/ea152465ex99-1_nightfood.htm
Valued Shareholders,
As we enter the last two weeks of the year, I’d like to take a moment to briefly reflect on the last twelve months and look towards the future.
We set upon 2021 as a transformative year for the Company and have made transformative progress in many areas. These include the launch of our new Nightfood “sleep-friendly” packaging, securing distribution in Walmart, our successful hotel pilot test with a leading international hotel chain with the expectation of widespread national hotel distribution in 2022, eliminating all variable-rate convertible debt, winning first place in the Real California Milk Excelerator Program (with a $150,000 prize), and building a highly-credentialed board of directors.
The outlook for 2022 includes a strategic focus on the higher-margin hotel vertical and the introduction of new snack formats in addition to our ice cream pints to potentially derive additional benefit from the hotel opportunity.
On December 10, 2021, we closed a financing round of approximately $1,000,000 from institutional investors. This secured debt is convertible initially at a price of $.25 per share of NGTF common stock, a 14% premium to the market closing price on the day the financing was consummated.
This financing projects to carry us into summer of 2022, at which time we expect to have Nightfood snacks available in thousands of hotel locations. Depending on the speed at which additional hotel chains and locations begin to offer Nightfood to their guests, profitability projects to be possible in this timeframe, as well.
Hotel Distribution
I have stated in the past that short-term profitability is not our primary goal. That remains true. I believe the most impactful factors in determining long-term shareholder value will be consumer acceptance of the concept of sleep-friendly snacking, the development of the night snack category, and establishing and maintaining the Nightfood brand’s leadership position within that category (in terms of both thought leadership and top-line revenue growth).
My belief is that widespread distribution in the hotel vertical can serve to advance all those factors. And, it projects to do so with more speed, and significantly stronger gross and net margins than traditional supermarket distribution.
As a result of our successful hotel pilot test initiated in early 2021, Nightfood received confirmation that our ice cream pints will be introduced for sale in the lobby shops of a leading international hotel chain. Previously, tentative timelines for this introduction had been set and subsequently pushed back with COVID-related delays. Last month we were presented for the first time with a firm and committed timeline from our initial hotel partner, which includes introduction into their freezers in the first quarter of calendar 2022. While COVID contributes a level of uncertainty into everything these days, we do not expect any additional delays, but that possibility remains. We are currently awaiting definitive purchase orders for the roll-out.
Vistar, the leading distributor of snacks and drinks in the hotel industry, is expected to begin stocking Nightfood in all twenty-one of their distribution centers across the country to service this first chain and subsequent new hotel accounts. We expect national Vistar distribution to directly lead to additional hotel chains and locations adding Nightfood for their guests. Based on ongoing discussions with other global hotel brands, we’re expecting additional corporate-level commitments from additional hotel chains in the first quarter of 2022 and beyond.
We have identified over 40 target hotel chains in the United States with properties that sell ice cream and other packaged snacks, totaling approximately 20,000 locations. Because we believe that hotels have an implied obligation to help guests sleep better, we believe Nightfood sleep-friendly snacks are a natural fit to become a hotel industry standard.
Based on pilot test numbers, we project to reach profitability with approximately 4,000 hotel locations with only ice cream pint sales. This would not include any of the additional snack formats we are exploring and are planning to launch. We have already received confirmation of interest from hotel decision makers in testing and adding our additional snack formats under development. Our goal is to secure widespread hotel distribution for ice cream pints and novelties, as well as other snack formats such as cookies, chips, candy, and nutrition bars.
In addition to projected profitability resulting from our hotel roll-out, widespread hotel distribution projects to accelerate consumer adoption of our category, driving awareness that what you eat at night can impact your sleep quality. We intend to leverage national hotel distribution to propel the night snack category into the consumer health spotlight. We expect distribution in leading global hotel chains to serve as an economic moat while bestowing credibility upon our brand that establishes and maintains Nightfood as the “category king”.
Supermarket Distribution
Because of the shift in our short-term focus to the projected higher-margin and faster-growth hotel vertical, we made the decision to present the Nightfood line to fewer new supermarket chains this year for new placement than in past years. Our plan is to grow our revenue and awareness base in hotels and then grow our supermarket footprint on the strength of our hotel distribution.
In our ongoing dialogue with buyers and category managers in several of the largest supermarket chains in the country, we notified them of the national hotel rollout timeline and of our plan to reengage them in the second half of 2022 to discuss distribution in 2023 and beyond.
Having been rotated out of distribution in Harris Teeter in September, and finding growth in other supermarket accounts, including Walmart, expensive, slow, and unpredictable, we see greater value in growth through the hotel vertical at this time. This value is rooted in the significantly lower cost of doing business, the better consumer/placement fit, and the ability to scale much more rapidly within a clearly-defined distribution niche, where we can sell our products at a premium price while insulated from the supermarket competition and price discounting wars.
During 2022, I expect Nightfood to add additional small and independent supermarkets through our distribution partnerships with KeHE and UNFI, with the possibility of adding one or two strategic supermarkets at the regional and/or national level.
Supermarket ice cream category reviews are generally held each year in the late summer and fall. When the next ice cream category review season begins in the second half of 2022, we expect to have Nightfood in thousands of hotel locations, potentially in multiple snack formats. At that point, we’d project to be presenting the Nightfood line to new potential supermarket partners as a brand with growing consumer awareness, consistent exposure, and significant ongoing consumer trial. I believe this will provide the foundation for a much more powerful launch into new supermarket chains, allowing us to be strategic and selective.
E-Commerce
Ice cream via E-commerce is not a strong source of potential revenue or profits because of poor unit economics resulting from typically high costs of customer acquisition and shipping and handling. Those unit economics make it an inefficient channel in which to scale.
In January 2022, we intend to increase prices on the BuyNightfood.com website for consumers ordering Nightfood pints by mail. The price increase will be significant on a percentage basis, likely up to $7.99 per pint from the current $5.99. We do not view the increase, in and of itself, as having any material impact on our revenues or profits, but it will drastically improve our unit economics.
This E-commerce pint price increase is being made in conjunction with other positive developments which could possibly have significant material impact. One of these developments is the introduction of a new Nightfood snack format which we believe would better lend itself to profitable E-commerce. We expect to be able to provide more details in the coming weeks about these initiatives.
Looking Forward
2021 has proven to be transformative in many ways. The Company has built a stronger foundation from which we believe we are poised to take additional major steps forward in 2022.
Consumer nighttime snacking shows no signs of slowing down and the focus on sleep quality continues to intensify in both media and academia. New studies released during the year support links between nighttime snacking and both sleep quality and work productivity.
With the ongoing focus on the importance of sleep, Unilever and Pepsi have both publicly stated that they are evaluating how nutrition can be used to affect better sleep quality. With an estimated 800,000,000 nighttime snacks being consumed every week in the United States, and much more globally, we expect interest in this space from large food and beverage companies to continue to grow during 2022 and beyond.
We believe the activity in this area from global CPG players signals that there is significant opportunity in the category Nightfood is pioneering and leading.
Having Nightfood sleep-friendly snacks launching into hotels across the country can be expected to advance both the Company and the category. We have confidence in our distribution, revenue, and profitability goals for calendar 2022. This confidence is based on our ongoing industry discussions combined with the hotel pint unit sales projections delivered to us post-test based on test period sales.
We believe there is a tipping point within the industry at which point Nightfood snacks will become hotel industry standard. We’re working with the team at iDEAL Hospitality Partners to reach that tipping point as quickly as possible.
We are excited to be able to share additional details of our scheduled winter hotel launch and the identity our first corporate-level hotel distribution partner in the coming weeks.
Wishing everybody who celebrates a happy, healthy, and joyous Christmas and Kwanzaa season, and a Happy New Year to all!
Sincerely,
Sean Folkson
Nightfood Founder & CEO
sean@nightfood.com
This letter may contain forward-looking statements. Words such as “will,” “may,” “would,” “could,” “projects,” “shall,” ‘‘expects,’’ ‘‘anticipates,’’ ‘‘approximates,’’ ‘‘believes,’’ ‘‘estimates,’’ ‘‘intends’’ and ‘‘hopes’’ and variations of such words and similar expressions are intended to identify such forward-looking statements. We have based these statements on our current expectations and projections about future events. These forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these statements. Such forward-looking statements involve risk and uncertainties, including, but not limited to, the acceptance of our products by retailers, distributors and end-users, commercialization risks, availability of financing and results of financing efforts, the impact on the Company’s business as a result of the COVID-19 pandemic, and general economic conditions. Further information regarding these and other risks, as well as other information about the Company, is described from time to time in the Company’s filings with the SEC, which can be accessed at www.sec.gov.
This letter should be read in conjunction with the Company’s annual, quarterly and other reports and schedules filed with the Securities and Exchange Commission from time to time, including the Company’s most recent Annual Report on Form 10-K for the fiscal year ended June 30, 2021 and Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2021.
$QNTA has champion skateboarder Tony Hawk on board to endorse their products in new commercial spots. This is an effective way to get new consumer attention, especially with the right fit as we see in this case. And I am sure Tony Hawk really does appreciate the QNTA superior pain management products.
Medolife Rx Announces Upcoming Release of New Aelia Commercials Featuring Tony Hawk
BURBANK, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), announced today its upcoming release of commercials featuring product spokesperson Tony Hawk. One commercial is planned to air on multiple social media platforms in November, with a holiday-themed commercial to follow up beginning of December. Various still images from the photoshoot will also be featured across social media platforms.
The Company continues working with renowned skateboarder Tony Hawk as its product spokesperson for its Aelia line of pain management products. In August, the Company participated in an in-person Vert Alert event, where it showcased its products to Olympic and pro athletes from all over the country, as well as the general public. Together, the Company and Tony Hawk are excited to share the new content, with the goal to entertain and educate on the ingredients that have been polarized by Medolife’s proprietary process that increases the potency of the active ingredients by up to five times.
“Everybody had a great time filming the commercials and I feel there is an even greater understanding among those that participated on what makes Aelia products so unique,” said Medolife CEO Dr. Arthur Mikaelian. “Tony was kind enough to give me a few lessons on riding a skateboard, and I was happy that Tony showed an interest in our science. We exchanged many laughs and look forward to our continued partnership. I would say my biggest takeaway from this experience is that I have a long way to go before I am as confident on a skateboard as I am about the efficacy of our products.”
In recent months, the Company has demonstrated tremendous progress in both its clinical development program as well as its direct-to-consumer nutraceutical product portfolio. It is in the process of completing a pharmacokinetic (PK) study on its lead drug candidate Escozine® per an instructional response from the US Food and Drug Administration (FDA) as it relates to the Company’s pre-Investigational New Drug (Pre-IND) application for Escozine®. Additionally, it has ramped up its sales and marketing initiatives on its consumer products including the attendance and sponsorship of the Tony Hawk Vert Alert event, where it showcased its revolutionary line of pain relief products and introduced its Immunapen™ line of products. The Company hopes to soon receive approval on their name and symbol change, which was announced earlier this year.
About Medolife Rx
Medolife Rx, Inc. is a global biotechnology company with operations in clinical research, manufacturing, and consumer products. Medolife Rx was created through the merger of Medolife, a private company founded by Dr. Arthur Mikaelian who pioneered the unlaying polarization technology that makes the Company’s portfolio of pharmaceutical and nutraceutical products so effective, and Quanta, Inc., a direct-to-consumer wellness product portfolio company. The Company’s lead clinical development programs include Escozine®, a proprietary formulation consisting of small molecule peptides derived from Rhopalurus princeps scorpions which is amplified by the Company’s polarization technology and is being researched as a treatment of various indications, including COVID-19 and cancer. The Company has completed preclinical safety and efficacy research on Escozine® and is pursuing product registration and drug approval in various countries, including the United States and throughout Latin America.
Through its subsidiary Aelia, Medolife manufactures and distributes consumer wellness and nutraceutical products in high-impact consumer areas such as pain relief, beauty, and general wellness. Aelia products are designed using Dr. Mikaelian’s polarization technology which applies advances in quantum biology to increase the potency of active ingredients. Currently, Aelia supports product formulations in pain management, anti-inflammation, skincare, agriculture, nutritional supplements, and plant-based consumables. Ultimately, Quanta's mission is to deliver better, more effective ingredients to elevate product efficacy, reduce waste, and facilitate healthier, more sustainable consumption.
Beyond its own clinical and consumer applications, the polarization technology used by Medolife and its subsidiaries has many potential applications. From potentiating bio-ingredients, to producing more-effective carbon-trapping plants, to transformative anti-aging solutions, Medolife has the opportunity to upend how commercial and pharmaceutical products are made and increase their benefits, while decreasing their chemical concentration.
Forward-Looking Statements
Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995: This release contains statements that are forward-looking in nature which express the beliefs and expectations of management including statements regarding the Company's expected results of operations or liquidity; statements concerning projections, predictions, expectations, estimates or forecasts as to our business, financial and operational results and future economic performance; and statements of management's goals and objectives and other similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by terminology such as "anticipate," "estimate," "plan," "project," "continuing," "ongoing," "expect," "we believe," "we intend," "may," "will," "should," "could," and similar expressions. Such statements are based on current plans, estimates and expectations and involve a number of known and unknown risks, uncertainties and other factors that could cause the Company's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. These factors and additional information are discussed in the Company's filings with the Securities and Exchange Commission and statements in this release should be evaluated in light of these important factors. Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.
Contacts:
ir@medoliferx.com
$SNNC The Company is proud to announce its agreement with Lifetime Branding Collaborative, https://www.globenewswire.com/news-release/2021/12/09/2349152/0/en/SIBANNAC-INC-AND-LIFETIME-BRANDING-ENTER-DEBT-FORGIVENESS-AGREEMENT.html
$AMIH for the increasingly important TeleHealth field of healthcare:
AMIH Announces Launch of Ambassador Program for its EPIQ MD Telehealth Platform
Introduces organic distribution strategy - combining community, entrepreneurship, and technology
Plano, Texas, Nov. 15, 2021 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB: AMIH), a diversified holding company that develops, acquires and operates technology-based health and wellness companies, today announced that its subsidiary EPIQ MD has launched its much-anticipated Ambassador Program. This groundbreaking initiative will combine community, entrepreneurship, and technology to bring healthcare solutions to the near 80 million uninsured and underinsured, hardworking U.S. residents who have been left behind by ever-increasing insurance and medical costs.
With the introduction of Epiq MD’s Ambassador Program, AMIH believes they have set up the perfect mix of direct sales and organic community involvement, both of which have been largely missing components in the traditional healthcare industry. Epiq MD’s Ambassador Program aims to bind entrepreneurship with stewardship in an innovative manner creating leaders in communities all across the nation. Accordingly, the Company is confident this will grant them a significant competitive advantage.
“I believe that Epiq MD’s Ambassador Program is both timely and the perfect outside-the-box strategy that can make a real difference in communities across our nation”, comments Jacob Cohen, President and CEO of AMIH. “This organic strategy will be able to not only spread the Epiq MD services across the nation but the Epiq MD message as well, which we feel is equally important at this time. It’s estimated that 79 million people are going to start home based businesses in the next 5 years. There’s a clear rising need and desire for people to become self-employed and we believe those who are passionate about health and wellness will be given their jump start through the Ambassador Program”, further comments Mr. Cohen.
Epiq MD’s Ambassador Program is not only shining a spotlight to the lack of attention given to the respective 80 million U.S. residents lacking sufficient health coverage, but providing Ambassadors with ongoing training and support. Epiq MD Director, Michael Ladner stated, “our target audience is everywhere, all-encompassing and quite literally for anyone. Healthcare and entrepreneurship have no class, color or age. This program will be instrumental in expanding Epiq MD’s reach and putting tools in the hands of the people who need them most.”
The Company believes that the aforementioned tools and information its Ambassador Program is providing will be vital in ushering in a new wave of affordable healthcare that millions across the nation will be able to benefit from. Michael Ladner further commented, “We are giving people the opportunity to build a portfolio of residual income and bring sought-after healthcare services to their communities. We believe the best way to reach people, is with people and our Ambassador Program is the embodiment of that.”
Creating trends and setting new ways of thinking is always a difficult task, especially in the healthcare industry, but by combining Epiq MD’s existing offerings with an innovative, community centered program, AMIH believes they can do just that. The company extensively plans for expansion, future deployments, and marketing events that will go through the end of 2022. For additional information and to view an intro video on EPIQ MD’s Ambassador Program, visit us at https://epiqmd.info.
About EPIQ MD, Inc.
EPIQ MD believes that everyone deserves to live an epic life. It is the convergence of primary medical and mental health care, preventative care and wellness programs - on one digital platform, in a single offering. Conceived as a digital telemedicine-based business from the start, its core mission is to bring these services and knowledge to the 80 million Americans who are uninsured or underinsured. Its telemedicine platform provides services such as primary care, medical advisory, ask a medical expert, mental health services, discounted diagnostic lab services, prescription discount program, nutritional counseling and much more. Today Epiq MD is active and operational in Alaska, Georgia, Illinois and Texas. For more information, please contact us at media@epiqmd.com or by phone at 1-844-8 EPIQ MD. EPIQ MD, Inc. is a wholly owned subsidiary of American International Holdings Corp. (AMIH). Get all the latest news and developments by following Epiq MD on social media outlets: Facebook, Instagram or Linked-In.
About American International Holdings Corp.
American International Holdings Corp. (OTCQB: AMIH) is an investor, developer and asset manager of diversified, synergistic health and wellness businesses. Today, the AMIH portfolio encompasses telemedicine and other virtual health platforms, affordable subscriber-based primary care and concierge medicine plans, preventative care solutions and wellness related assets such as mental & behavioral health services, as well as its own proprietary life coaching platform. AMIH markets its various services through direct-to-consumer and business-to-business distribution channels. AMIH’s focus is on bringing to market technologies and solutions that advance the quality of life for the global community.
Forward-Looking Statements
This press release may contain forward-looking statements, including information about management’s view of the Company’s future expectations, plans and prospects, including within the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 (the “Act”). Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, operations, expansion, earnings, cash flows, results of operations, uses of cash and other measures of financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the Company, and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. These risk factors and others are included from time to time in filings made by the Company with the Securities and Exchange Commission, including, but not limited to, in the “Risk Factors” sections in its Form 10-Ks and Form 10-Qs and in its Form 8-Ks, which it has filed, and files from time to time, with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov. The forward-looking statements included in this press release are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.
Investors Relations Contact
Frank Benedetto
(619) 915-9422
https://www.globenewswire.com/newsroom/ti?nf=ODM5MzI5MCM0NTUxNTk2IzUwMDA2NjY0Ng==
https://ml.globenewswire.com/media/NDZiN2RkNWEtZmZlYi00YTE2LWJlZDUtMTcxYmQyZWFlNDJmLTUwMDA2NjY0Ng==/tiny/American-International-Holding.png
Source: American International Holdings Corp.
$SWRM $TGHI $RIII TulsaLabs Launches Aerospace Division for Commercial and Military Projects https://www.globenewswire.com/news-release/2021/11/19/2338351/0/en/TulsaLabs-Launches-Aerospace-Division-for-Commercial-and-Military-Projects.html
$NGTF - News on high profile marketing and media exposure this week...
Nightfood Secures Spot in Real California Milk Excelerator Innovation Program Finals, Ice Cream Sandwiches Under Development for Hotel Lobby Shops
Pioneering night snack brand to offer hotels more options and convenient single serve items
Tarrytown, NY, Oct. 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nightfood Holdings, Inc. (OTCQB: NGTF), the better-for-you snack company addressing the $50 billion Americans spend annually on night snacks, has announced it is developing Nightfood ice cream sandwiches for single-serve retail sale in hotel lobby shops across the country.
The Company won its semi-final round in the Real California Milk 2021 Excelerator program presented by the California Milk Advisory Board (CMAB) and VentureFuel. As a result, Nightfood will be one of four finalists competing for two six-figure prizes to invest in marketing support for innovative dairy products made with milk from California. The finals will take place November 18, 2021 at 8 pm eastern time. Interested parties are encouraged to pre-register here to observe the event live.
The industry expert judges, in their determination of the winners of the semi-final round, expressed a belief that Nightfood having sleep-friendly snack products widely available in hotels was a creative and powerful channel strategy which they believed could power the brand to mainstream success.
Industry sources estimate approximately 20,000 American hotels currently sell ice cream in their freezers, and that number is growing. The Nightfood ice cream sandwich is being developed with a focus on distribution in the hotel space, with possible supermarket introduction thereafter.
“As our pints are expected to soon be launching in hotels all across the country, we’re excited about expanding our offerings,” commented Nightfood CEO Sean Folkson. “Having both single serve novelties and 16-ounce pints in the hotel freezer together can drive higher unit sales, which means more consumer trial of the Nightfood brand. We’d expect that to then result in additional sales velocity growth in our supermarket accounts.”
Data from hotel grab-and-go industry leader Impulsify reveal that all ten of the top-ten best-selling hotel ice cream products are either single serve novelties or single-serve cups. Such items are reported to make up over 70% of hotel ice cream unit sales. Pints, because of their higher retail price point, are reported to account for almost 50% of all category dollar sales.
The Impulsify 2021 hotel retail guide, Grab & Go For It!, reported, “Ice cream ranked in the top 3 highest performing categories with novelties outselling cups and pints. Guests are consuming the treat in record numbers.”
Nightfood management believes hotels have an obligation to facilitate quality sleep for their guests. This obligation goes beyond comfort and quiet; it also includes nutrition. Management believes hotels will move towards making sleep-friendly night snack options readily available on premises in many popular snack formats, not just ice cream.
With help from the CMAB, the Company is working to secure California-based copacker production capacity for the ice cream sandwiches, which will then be presented to hotel decision-makers for inclusion in their freezer assortment. Production would begin when the Company has secured a hotel distribution commitment for the ice cream sandwich line.
About Nightfood: Pioneering the Night Snack Category
Over 80% of Americans snack regularly at night, resulting in an estimated 700 million nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion. The most popular choices are ice cream, cookies, chips, and candy. Recent research confirms these snacks, in addition to being generally unhealthy, can impair sleep due to excess fat and sugar consumed before bed.
Nightfood is pioneering the category of night snacks. Nightfood ice cream, the brand’s first mainstream product, is uniquely formulated by sleep and nutrition experts to contain less of those sleep-disruptive ingredients, along with a focus on ingredients and nutrients that research suggests can support nighttime relaxation and better sleep quality.
Unlike regular ice cream, Nightfood was formulated to contain more tryptophan, vitamin B6, calcium, magnesium, zinc, prebiotic fiber, and casein protein. It also has less sugar, less fat, and a lower glycemic profile. Because of its great taste and unique nutritional profile, Nightfood has been endorsed as the Official Ice Cream of the American Pregnancy Association and is the recommended ice cream for pregnant women.
The brand won the 2019 Product of the Year award in the ice cream category in a Kantar survey of over 40,000 consumers. Nightfood was also named Best New Ice Cream in the 2019 World Dairy Innovation Awards.
Nightfood ice cream is available in divisions of Walmart, Albertson’s, and H-E-B, as well as many regional supermarket chains and independent retailers, and select hotel locations.
Questions can be directed to investors@Nightfood.com
Management also encourages Nightfood shareholders to connect with the Company via these methods:
E-mail: By signing up at ir.nightfood.com, investors can receive updates of filings and news releases in their inbox.
Telegram: There is now a live, interactive Telegram group which interested parties can join to reach team members and discuss Nightfood. Ask questions, learn more about the company and discuss future prospects. Join the Telegram Group Here: https://t.me/NightfoodHoldings
About Real California Milk/California Milk Advisory Board
The California Milk Advisory Board (CMAB), an instrumentality of the California Department of Food and Agriculture, is funded by the state’s dairy farm families who lead the nation in sustainable dairy farming practices. With a vision to nourish the world with the wholesome goodness of Real California Milk, the CMAB’s programs focus on increasing demand for California’s sustainable dairy products in the state, across the U.S. and around the world through advertising, public relations, research, and retail and foodservice promotional programs. For more information and to connect with the CMAB, visit RealCaliforniaMilk.com, Facebook, YouTube, Twitter, Instagram and Pinterest.
About VentureFuel, Inc.
Founded in 2014, VentureFuel is an independent innovation consultancy that builds innovation programs for industry leaders by unlocking the power of external innovation through startup collaboration. Its programs focus on changing behaviors and beliefs in order to unlock new sources of growth. We provide senior leaders with the tools to drive transformative change within their organizations by opening up their teams to new ways of working, products, services and routes to market. Learn more at: www.venturefuel.net, Linked-In, Twitter and Instagram. You can hear The VentureFuel Podcast on Apple, Spotify or Simplecast.
Forward Looking Statements:
This current press release contains "forward-looking statements. Statements in this press release which are not purely historical (including, but not limited to statements that contain words such as “will,” “believes,” “plans,” “anticipates,” “expects” and “estimates”) are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Media Contact:
Kevin Farrell
Notably
media@Nightfood.com
215-760-7547
Investor Contact:
Stuart Smith
SmallCapVoice
investors@nightfood.com
888-888-6444, x3
https://www.globenewswire.com/newsroom/ti?nf=ODM4MjEzMyM0NTIwMDkxIzUwMDAzMzQ0Nw==
https://ml.globenewswire.com/media/NGFmYzdlYTItMjg3MS00Y2RiLWJhYTItYTY5ODk1YWI2NmI3LTUwMDAzMzQ0Nw==/tiny/NightFood-Holdings-Inc-.png
Source: NightFood Holdings, Inc.
Nikola Motor Company -$NKLA - Nikola Holiday Bike Fundraiser with Phoenix Children's Hospital
Nikola Motor Company -$NKLA - Nikola Holiday Bike Fundraiser with Phoenix Children's Hospital
$GTOR is showing up big and green on the ticker buzz cloud https://investorshub.advfn.com/boards/tcloud2.aspx
$GTOR- all hands on deck . The trade is setting up for a massive move north with solid forward moving news first of next week.
https://twitter.com/jctb1/status/1461358897839546368?s=20
$MAPT News: Maptelligent, Inc. is Pleased to Announce Its New Strategic Partnership With the Award-winning Kant Consulting Group
https://www.globenewswire.com/news-release/2021/08/03/2273436/0/en/Maptelligent-Inc-is-Pleased-to-Announce-Its-New-Strategic-Partnership-With-the-Award-winning-Kant-Consulting-Group.html
About Maptelligent, Inc., (OTC Pink: MAPT) ("the Company"), the developer of a robust data management platform designed to improve emergency responses dedicated to using state-of-art indoor mapping technology to ensure the places where we work, play, worship, and routinely visit are safe, sustainable, and operate more efficiently. For more info go to http://www.maptelligent.com.
$SMME is an innovation leader for the increasingly vital field of payment card security. The latest example of this expertise is the anti-spoofing tech that can defeat fake fingerprints which is a just-in-time solution that card users need today.
From the SMME news:
SmartMetric, Inc. (OTCQB: SMME): SmartMetric has invented a hardware and software solution that detects whether or not the finger being used to activate the card is from an actual person or not.
This "liveness detection" anti-spoofing technology developed by SmartMetric is designed to defeat attempted use of fake fingerprints using such things as a copy of a person's fingerprint replicated using a silicon fingerprint replica.
"As we move forward with greater and more valuable transaction applications for our biometric credit and debit cards, it was apparent to us that we needed to implement the highest level of biometric protection we could," said SmartMetric’s President & CEO, Chaya Hendrick, today.
SOURCE:
https://finance.yahoo.com/news/smartmetric-announces-breakthrough-anti-spoofing-182800140.html
$MAPT: The company is committed to growing its position in the increasingly important field of security management for a wide range of applications. The new strategic partnership with the Kant Group should yield an strong expansion of MAPT business going forward so I would expect to see more updates in addition to the initial news.
Maptelligent, Inc. is Pleased to Announce Its New Strategic Partnership With the Award-winning Kant Consulting Group
LAS VEGAS, NV, Aug. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc. (OTC PK: MAPT) www.maptelligent.com:
Furthering its dedication to being a leader in the Indoor Mapping Intelligence for a safer and more efficient physical environment, Maptelligent, Inc. is pleased to announce its new strategic partnership with the award-winning Kant Consulting Group, specialized consulting, and innovation services company.
Maptelligent’s leadership is committed to bringing the latest in indoor mapping capability to its customers, providing an unparalleled digital twin solution set that uncovers actionable intelligence in your building information management data. The strategic partnership between Maptelligent, Inc. and Kant Consulting Group will provide ongoing research and development on no code/low code enhancements, IoT interoperability, block chain and augmented reality, allowing Maptelligent, Inc. customers to benefit from the latest in information technology, platform as a service, agile development and digital twin capabilities.
Kant Consulting Group’s understanding of innovation, its deep integration expertise, and collaborative methodology are uniquely complementary to Maptelligent, Inc. Mr. Eric Kant of Kant Consulting Group https://www.linkedin.com/in/ekant/ says, “The partnership with Maptelligent, Inc. is positive confirmation that our unique approach when combined with a suitable partnership can cut the multi-year development cycle of new capabilities down to months and days. Maptelligent, Inc. is uniquely positioned to adjust quickly to customers’ needs and provide innovative cutting-edge digital twin capability.”
Mr. Joseph Cosio-Barron, CEO for Maptelligent, Inc., says, “The strategic partnership with the Kant Consulting Group offers us significant potential in all the markets we serve. The expertise that the Kant Consulting Group has built will bolster our growth in the specialty space of indoor mapping capabilities.”
Joe Cosio-Barron
415-990-8141
joe.cosio-barron@maptelligent.com
$DSCR watch and load... Hearing News dropping any day now! @JJTrader4 @jctb1
$LCLP News! Gartner-Ranked Belrium Blockchain steps up Real World DAPPs rollout in anticipation of Life Clips’ acquisition of Belfrics Group https://finance.yahoo.com/news/gartner-ranked-belrium-blockchain-steps-113000574.html
#BreakingNews! $WHSI Acquires Cutting Edge Backend-as-a-Service (Baas) Enterprise Software Dealer Platform; Integrating the Company’s New iHelp Max(TM) on the Management & Automation Platform @TENAssociates https://finance.yahoo.com/news/whsi-acquires-cutting-edge-backend-123000564.html
$CEMI About the DPP Rapid Test Platform
Chembio’s proprietary DPP technology platform provides high-quality, rapid diagnostic results in 15 to 20 minutes using a small drop of blood from the fingertip or alternative samples. Through advanced multiplexing, the DPP platform can detect up to eight, distinct test results from a single patient sample, delivering greater clinical value than other rapid tests. For certain applications, Chembio’s easy-to-use, highly portable, battery-operated DPP Micro Reader optical analyzer then reports accurate results in approximately 15 seconds, making it well-suited for decentralized testing where real-time results enable patients to be clinically assessed while they are still on-site. Objective results produced by the DPP Micro Reader reduce the possibility of the types of human error that can be experienced in the visual interpretations required by many rapid tests.
Chembio’s portfolio of DPP-based point-of-care tests with FDA regulatory approvals include the DPP HIV-Syphilis System (PMA approved), DPP HIV 1/2 Assay (PMA approved and CLIA waived), DPP Zika IgM System (510(k)), and DPP Ebola Antigen System (EUA). Additionally, DPP-based tests have received regulatory approvals from the World Health Organization, CE-Mark, ANVISA, and other global organizations, where they aid in the detection and diagnosis of several other critical diseases and conditions.
All DPP tests are developed and manufactured in the United States and are the subject of a range of domestic and global patents and patents pending. https://chembio.com/investors/press-releases/
$MDXL Potential Squeeze From These Levels
$DSCR ON RADAR $$$ expecting big things!
$BANT has as commenced the sale of its sanitizing franchises. Considering all the focus in the daily news on safer re-openings for all kinds of facilities and the initial response that BANT has been receiving, we should see very positive results for the company.
Bantec Begins Selling Bantec Sanitizing Franchises This Week
LITTLE FALLS, N.J., Aug. 5, 2021 /PRNewswire/ -- Bantec, Inc. (OTCPINK: BANT) ("Bantec" or the "Company"), through its subsidiary Bantec Sanitizing will start selling franchises this week.Michael Bannon, Bantec's Chairman and CEO stated: "We are excited to start selling Bantec Sanitizing Franchises this week.
With the Covid-19 Delta variant, and other possible variants, along with other potential virulent pathogens on the horizon, we believe, through Bantec Sanitizing Franchisees, we are in a great position to help businesses keep their employees and customers safe. Over last few months, we received many Bantec Sanitizing franchisee inquiries. We are now ready to market and sell franchises. We expect income from sales of franchises to substantially add to our bottom line this year. Below, I included our marketing and sales contact's email at Accurate Franchise Incorporated (AFI)".
John Brice, VP of Sales & Marketing for AFI.
Email address: jbrice@ufgcorp.com. (UFG Corp parent to AFI)
About Bantec Sanitizing
Bantec Sanitizing, a division of Bantec, provides a variety of products and services to help facility managers, safety professionals, and maintenance personnel combat a multitude of airborne and surface hazards. On February 3, 2021, Bantec announced that it will offer Bantec Sanitizing (Exposure Response Mobile Service) as a Franchise. Future Bantec Sanitizing franchisees will offer Bantec Sanitizing supplies, robots, UV lights, drone sanitizing, spraying, and deep cleaning services. The world, as we knew it, changed with Covid-19; the way we view sanitizing and deep cleaning will never be the same".Bantec Sanitizing: http://www.bantec.store
About Bantec
Bantec, Inc., a product and services company, through its subsidiaries and divisions, sells to facility managers, engineers, maintenance managers, purchasing managers and contract officers who work for hospitals, universities, manufacturers, commercial businesses, local and state governments, and the US government. We intend to grow different business lines, including using the franchise model, that support the customers described above.
Forward-Looking Statements
Certain statements in this press release may be considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include projections of matters that affect revenue, operating expenses, or net earnings; projections of growth; and assumptions relating to the foregoing. Such forward-looking statements are generally qualified by terms such as: "plans, "anticipates," "expects," "believes" or similar words. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or qualified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking information. These factors are discussed in greater detail in our most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission.
Contacts:
Michael BannonChairman & CEO
mike@bantecinc.com
(203) 410-8924
https://c212.net/c/img/favicon.png?sn=LN66473&sd=2021-08-05 ;
View original content:https://www.prnewswire.com/news-releases/bantec-begins-selling-bantec-sanitizing-franchises-this-week-301349448.html
SOURCE Bantek Inc.
$CLSH on strong alert in the .15 - .16 range. CLSH has only a 29M float and announced earlier this week increased margins and and endorsement deal for June. Expecting to see a strong move soon #MJ #LasVegas >>
Heating Up: CLS Holdings USA, Inc. Announces June Results, Increased Margins and Endorsement Deal
https://www.clsholdingsinc.com/news-media/press-releases/detail/156/heating-up-cls-holdings-usa-inc-announces-june-results
Investors Presentation:
https://d1io3yog0oux5.cloudfront.net/_da249485e7bf1548e4ad8b3dcdeeaaa9/clsholdingsinc/db/495/5015/pdf/CLS+Investor+Presentation+5.1.2021+Update+v4.pdf
$SNDL Sundial Growers Inc. engages in production and marketing of cannabis products for the adult-use market in Canada. It produces and distributes inhalable products, such as flower, pre-rolls, and vapes. The company offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. Sundial Growers Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
$ACGX is delivering solid returns from its business in the important products packaging sector which serves a wide range of clients.
Alliance Creative Group (ACGX) Reports Total Revenue of $2,613,997 for First Quarter of 2021 with Net Income of $256,799
2021 Quarterly Net Income increased by $237,206 compared to Q1 2020
CHICAGO, May 14, 2021 /PRNewswire/ -- Alliance Creative Group, Inc., (http://www.AllianceCreativeGroup.com) (Stock Symbol OTC: ACGX) is pleased to announce the results of Operations for the Three Months Ending March 31, 2021.
Revenues for the quarter ending March 31, 2021 ("Q1 2021") were $2,613,997
Gross Profits for the quarter ending March 31, 2021 ("Q1 2021") were $550,944
Net Income for the quarter ending March 31, 2021 ("Q1 2021") were $256,799
The total assets on the Balance Sheet for the Alliance Creative Group as of 3/31/21 were $3,587,857.
The total outstanding common shares as of March 31, 2021 ("Q1 2021") were 1,639,611 with 1,149,023 of those shares in the float.
The Company ended the quarter and year with ($7,257) Cash on hand.
Total Stockholder Equity as of 03/31/21 was $1,532,890
The full financial statement, balance sheet, statement of operations, cash flow statement, and disclosure statements are posted on the OTC Market Company website at www.OTCmarkets.com under the stock symbol ACGX in the section for filings and disclosure and on www.ACGX.us in the investor relations section.
Steve St. Louis, CEO of the Alliance Creative Group, Inc., said, "The first Quarter of 2021 ended with our largest Net Income in a long time, mostly due to the PPP forgiveness, but we were able to pay down more liabilities to get us in a stronger position for the future. We will continue to evaluate all our options and ideas to hopefully maintain and improve the positive progress for 2021 and beyond."
About Alliance Creative Group, Inc.
Alliance Creative Group, Inc. (Stock Symbol: ACGX) is a Packaging Solutions Company focused on Retail Packaging and Packaging Management. ACG helps its clients from initial concept and packaging development through final production and managed inventory solutions. The core business has been around since 1997. ACG currently focuses mostly on providing solutions for flexible and clear packaging, folding cartons, vendor managed inventory supply chain services and fulfillment. Additional services include but are not limited to corrugated boxes, commercial printing, labels, and other products and services related to the printing or packaging of consumer products. ACG's team includes experts to provide high-quality packaging and printed products. The ACG experience includes very hands-on operational support out of 6 different warehouse locations and several national and international manufacturing partners. ACG provides customer support during the entire product process or cycle including but not limited to creating, warehousing, delivering, and replenishing their packaging products For more information, visit www.AllianceCreativeGroup.com or www.ACGX.us.
About PeopleVine
PeopleVine is a consolidated platform that allows businesses to build more personal relationships with their customers at scale. PeopleVine solves the problem businesses have creating and managing holistic relationships with their customers without using multiple products that only support a portion of the relationship building activities. PeopleVine seamlessly brings together the tools needed to market, sell, and operate a business with streamline efficiencies in a customer engagement suite and enables businesses to make data informed decisions to help generate revenue growth.
We are committed to being the most essential and adaptive SaaS engagement platform for companies that take a customer centric approach to business.
For more information www.PeopleVine.com
This news release contains forward-looking statements as defined by the bespeaks-caution doctrine. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks described in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
Investor Relations and Media Contact
1-847-885-1800
Info@ACGemail.com
https://c212.net/c/img/favicon.png?sn=LN77870&sd=2021-05-14 View original content:http://www.prnewswire.com/news-releases/alliance-creative-group-acgx-reports-total-revenue-of-2-613-997-for-first-quarter-of-2021-with-net-income-of-256-799--301291364.html
SOURCE Alliance Creative Group, Inc.
$IDEX 2021 Earth Day MEG China
Followers
|
186
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9453
|
Created
|
07/21/11
|
Type
|
Free
|
Moderator Trooperstocks | |||
Assistants Robertscott |
Posts Today
|
0
|
Posts (Total)
|
9453
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads